Technical Analysis for PTHL - Pheton Holdings Ltd

Grade Last Price % Change Price Change
D 3.86 -3.50% -0.14
PTHL closed down 3.5 percent on Friday, November 1, 2024, on 51 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Down

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -3.50%
Lower Bollinger Band Touch Weakness -3.50%
Oversold Stochastic Weakness -3.50%
Wide Bands Range Expansion -8.53%
Gapped Up Strength -8.53%
Oversold Stochastic Weakness -8.53%
New Downtrend Bearish -5.85%

   Recent Intraday Alerts

Alert Time
Up 5% about 14 hours ago
Down 5% about 16 hours ago
Down 3% about 16 hours ago
Up 3% about 16 hours ago
Fell Below Lower Bollinger Band about 16 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD
Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Cancer Tumor Radiation Radiation Therapy Medical Physics Healthcare Solution Brachytherapy Malignant Tumors

Is PTHL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.45
52 Week Low 3.32
Average Volume 225,887
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 4.73
10-Day Moving Average 4.42
Average True Range 0.60
RSI (14) 31.97
ADX 28.52
+DI 13.84
-DI 20.22
Chandelier Exit (Long, 3 ATRs) 4.64
Chandelier Exit (Short, 3 ATRs) 5.35
Upper Bollinger Bands 5.69
Lower Bollinger Band 3.78
Percent B (%b) 0.04
BandWidth 40.25
MACD Line -0.14
MACD Signal Line 0.02
MACD Histogram -0.1584
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.00
Resistance 3 (R3) 5.02 4.67 4.81
Resistance 2 (R2) 4.67 4.38 4.65 4.75
Resistance 1 (R1) 4.26 4.20 4.08 4.24 4.68
Pivot Point 3.91 3.91 3.82 3.89 3.91
Support 1 (S1) 3.50 3.62 3.33 3.48 3.04
Support 2 (S2) 3.15 3.44 3.14 2.97
Support 3 (S3) 2.74 3.15 2.91
Support 4 (S4) 2.72